Renoprevention: A New Concept for Reengineering Nephrology Care—An Economic Impact and Patient Outcome Analysis of Two Hypothetical Patient Management Paradigms in the CCU

REFERENCES

• Ishani A, Xue JL, Himmelfarb J, . Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol. 2009;20:223–228.
   PubMed Web of Science ®Google Scholar
• Okusa MD, Chertow GM, Portilla D. Acute Kidney Injury Advisory Group of the American Society of Nephrology. The nexus of acute kidney injury, chronic kidney disease, and World Kidney Day 2009. Clin J Am Soc Nephrol. 2009;4(3):520–522.
   PubMedGoogle Scholar
• Onuigbo MA. Syndrome of rapid-onset end-stage renal disease (SORO-ESRD): a new unrecognized pattern of CKD progression to ESRD [Abstract]. J Am Soc Nephrol. 2010; 21:614A [SA−PO2198].
   Google Scholar
• Onuigbo MA. Syndrome of rapid-onset end-stage renal disease: a new unrecognized pattern of CKD progression to ESRD. Ren Fail. 2010;32(8):954–958.
   PubMed Web of Science ®Google Scholar
• Onuigbo MAC, Onuigbo N. Syndrome of rapid onset end-stage renal disease revisited—observations from two chronic kidney disease populations in two continents. US Nephrology. 2010; 5(2):81–85.
   Google Scholar
• Onuigbo MA, Onuigbo N. Chronic Kidney Disease and RAAS Blockade: A New View of Renoprotection. London: Lambert Academic Publishing GmbH 11 & Co. KG; 2011.
   Google Scholar
• Onuigbo M, Onuigbo N. The syndrome of rapid onset end-stage renal disease (SOROESRD)—a new Mayo Clinic dialysis services experience, January 2010–February 2011. In: Di Iorio B, Heidland A, Onuigbo M, Ronco C, eds. Hemodialysis: How, When and Why. Hauppauge, NY: NOVA Science; 2012. (In Print).
   Google Scholar
• Onuigbo M, Onuigbo N. Evidence of the syndrome of rapid onset end stage renal disease (SOROESRD) in the acute kidney injury (AKI) literature—preventable causes of AKI and SORO-ESRD—a call for re-engineering of nephrology practice paradigms [Abstract]. Perit Dial Int. 2012;32(Suppl. 1):S4.
   PubMedGoogle Scholar
• Firth JD. Acute irreversible renal failure [editorial]. Q J Med. 1996;89:397–399.
   Google Scholar
• Hsu CY. Linking the population epidemiology of acute renal failure, chronic kidney disease and end-stage renal disease. Curr Opin Nephrol Hypertens. 2007;16(3):221–226.
   PubMed Web of Science ®Google Scholar
• Hsu CY, Ordonez JD, Chertow GM, Fan D, McCulloch CE, Go AS. The risk of acute renal failure in patients with chronic kidney disease. Kidney Int. 2008;74:101–107.
   PubMed Web of Science ®Google Scholar
• Coca SG, Yusuf B, Shlipak MG, Garg AX, Parikh CR. Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis. 2009;53(6):961–973.
   PubMed Web of Science ®Google Scholar
• Khosla N, Soroko SB, Chertow GM, . Preexisting chronic kidney disease: a potential for improved outcomes from acute kidney injury. Clin J Am Soc Nephrol. 2009;4:1914–1919.
   PubMed Web of Science ®Google Scholar
• Lo LJ, Go AS, Chertow GM, . Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease. Kidney Int. 2009;76:893–899.
   PubMed Web of Science ®Google Scholar
• Thakar CV, Quate-Operacz M, Leonard AC, Eckman MH. Outcomes of hemodialysis patients in a long-term care hospital setting: a single-center study. Am J Kidney Dis. 2010; 55(2):300–306.
   PubMed Web of Science ®Google Scholar
• Waikar SS, Winkelmayer WC. Chronic on acute renal failure: long-term implications of severe acute kidney injury. J Am Med Assoc. 2009;302:1227–1229.
   Web of Science ®Google Scholar
• Wald R, Quinn RR, Luo J, . Chronic dialysis and death among survivors of acute kidney injury requiring dialysis. J Am Med Assoc. 2009;302:1179–1185.
   PubMed Web of Science ®Google Scholar
• Onuigbo MA, Onuigbo NT. Late onset renal failure from angiotensin blockade (LORFFAB): a prospective thirty-month Mayo Health System clinic experience. Med Sci Monit. 2005;11:CR462–CR469.
   PubMed Web of Science ®Google Scholar
• Onuigbo MA, Onuigbo NT. Use of ultrahigh RAAS blockade: Implications for exacerbation of renal failure. Kidney Int. 2006;69:194–195.
   PubMed Web of Science ®Google Scholar
• Onuigbo MA, Onuigbo NT. Late-onset renal failure from RAAS blockade. Kidney Int. 2006;70:1378–1379.
   PubMed Web of Science ®Google Scholar
• Onuigbo M, Onuigbo N. Renal failure from RAAS blockade in CKD patients: a prospective 50-month analysis–a call for pragmatic caution to optimize cardiorenal protection with RAAS blockade [Abstract]. Am J Kidney Dis. 2007;49(4):A64.
   Web of Science ®Google Scholar
• Onuigbo MA, Onuigbo NT. Late-onset renal failure from angiotensin blockade (LORFFAB) in 100 CKD patients. Int Urol Nephrol. 2008;40:233–239.
   PubMed Web of Science ®Google Scholar
• Onuigbo MA. Is renoprotection with RAAS blockade a failed paradigm? Have we learnt any lessons so far? Int J Clin Pract. 2010;64(10):1341–1346. PMID:20716141. DOI:10.1111/j.1742–1241.2010.02448Sep.
   PubMed Web of Science ®Google Scholar
• Onuigbo MA, Can ACE. Inhibitors and angiotensin receptor blockers be detrimental in CKD patients? Nephron Clin Pract. 2011;118(4):c407–c419.
   Google Scholar
• Onuigbo MAC. Reno-prevention vs. reno-protection: A critical re-appraisal of the evidence-base from the large RAAS blockade trials after ONTARGET—A call for more circumspection. QJM. 2009;102:155–167.
   PubMed Web of Science ®Google Scholar
• Onuigbo MA, Onuigbo NT. Does renin-angiotensin aldosterone system blockade exacerbate contrast-induced nephropathy in patients with chronic kidney disease? A prospective 50-month Mayo Clinic study. Ren Fail. 2008;30:67–72.
   PubMed Web of Science ®Google Scholar
• Onuigbo MA, Onuigbo NT. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis. QJM. 2008;101:519–527.
   PubMed Web of Science ®Google Scholar
• Onuigbo MA, Onuigbo NT. Renal failure and concurrent RAAS blockade in older CKD patients with renal artery stenosis: an extended Mayo Clinic prospective 63-month experience. Ren Fail. 2008;30:363–371.
   PubMed Web of Science ®Google Scholar
• Onuigbo MA. Does concurrent renin-angiotensin-aldosterone blockade in (older) chronic kidney disease patients play a role in the acute renal failure epidemic in US hospitalized patients?—three cases of severe acute renal failure encountered in a northwestern Wisconsin Nephrology practice. Hemodial Int. 2009;13(Suppl. 1):S24–S29.
   Google Scholar
• Onuigbo MAC. An analytical review of the evidence-base for reno-protection from the large RAAS blockade trials after ONTARGET. Re-visitation of the potential for iatrogenic renal failure with RAAS blockade? A call for caution. Nephron Clin Pract. 2009;113(2):c63–c69.
   Google Scholar
• Onuigbo MA. The impact of stopping inhibitors of the renin-angiotensin system in patients with advanced chronic kidney disease. Nephrol Dial Transplant. 2010;25(4):1344–1345.
   PubMed Web of Science ®Google Scholar
• Louis BM, Hoch BS, Hernandez C, . Protection from the nephrotoxicity of contrast dye. Renal Fail. 1996;18(4):639–646.
   PubMed Web of Science ®Google Scholar
• Markowitz GS, Nasr SH, Klein P, . Renal failure due to acute nephrocalcinosis following oral sodium phosphate bowel cleansing. Hum Pathol. 2004;35(6):675–684.
   PubMed Web of Science ®Google Scholar
• Rose M, Karlstadt RG, Walker K. Renal failure following bowel cleansing with a sodium phosphate purgative. Nephrol Dial Transplant. 2005;20(7):1518–1519.
   PubMed Web of Science ®Google Scholar
• Russmann S, Lamerato L, Marfatia A, . Risk of impaired renal function after colonoscopy: a cohort study in patients receiving either oral sodium phosphate or polyethylene glycol. Am J Gastroenterol. 2007;102(12):2655–2663.
   PubMed Web of Science ®Google Scholar
• Komenda P, Zalunardo N, Burnett S, et al. Conservative outpatient renoprotective protocol in patients with low GFR undergoing contrast angiography: a case series. Clin Exp Nephrol. 2007;11(3):209–213.
   PubMedGoogle Scholar
• Khurana A, McLean L, Atkinson S, Foulks CJ. The effect of oral sodium phosphate drug products on renal function in adults undergoing bowel endoscopy. Arch Intern Med. 2008; 168(6):593–597.
   PubMedGoogle Scholar
• Arora P, Rajagopalam S, Ranjan R, . Preoperative use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers is associated with increased risk for acute kidney injury after cardiovascular surgery. Clin J Am Soc Nephrol. 2008; 3(5):1266–1273.
   PubMed Web of Science ®Google Scholar
• Navarro I, Poveda R, Torras J, Castelao AM, Grinyó JM. Acute renal failure associated to renin angiotensin system (RAS) inhibitors—its burden in a nephrology department. Nephrol Dial Transplant. 2008;23(1):413–414.
   PubMed Web of Science ®Google Scholar
• Eddy AA, Neilson EG. Chronic kidney disease progression. J Am Soc Nephrol. 2006;17:2964–2966.
   PubMed Web of Science ®Google Scholar
• Merino GE, Buselmeier TJ, Kjellstrand CM. Postoperative chronic renal failure: a new syndrome? Ann Surg. 1975;182(1): 37–44.
   PubMed Web of Science ®Google Scholar
• Kjellstrand CM, Ebben J, Davin T. Time of death, recovery of renal function, development of chronic renal failure and need for chronic hemodialysis in patients with acute tubular necrosis. Trans Am Soc Artif Intern Organs. 1981;27:45–50.
   PubMedGoogle Scholar
• Bonomini V, Stefoni S, Vangelista A. Long-term patient and renal prognosis in acute renal failure. Nephron. 1984;36(3):169–172.
   PubMed Web of Science ®Google Scholar
• Lámeire N, Matthys E, Vanholder R, . Causes and prognosis of acute renal failure in elderly patients. Nephrol Dial Transplant. 1987;2(5):316–322.
   PubMedGoogle Scholar
• Bhandari S, Turney JH. Survivors of acute renal failure who do not recover renal function. QJM. 1996;89(6):415–421.
   PubMed Web of Science ®Google Scholar
• Robertson S, Newbigging K, Isles CG, Brammah A, Allan A, Norrie J. High incidence of renal failure requiring short-term dialysis: a prospective observational study. QJM. 2002;95(9):585–590.
   PubMed Web of Science ®Google Scholar
• Al-Homrany M. Epidemiology of acute renal failure in hospitalized patients: experience from southern Saudi Arabia. East Mediterr Health J. 2003;9(5–6):1061–1067.
   PubMedGoogle Scholar
• Yehia M, Collins JF, Beca J. Acute renal failure in patients with pre-existing renal dysfunction following coronary artery bypass grafting. Nephrology (Carlton). 2005;10(6):541–543.
   PubMed Web of Science ®Google Scholar
• Bahar I, Akgul A, Ozatik MA, . Acute renal failure following open heart surgery: risk factors and prognosis. Perfusion. 2005; 20(6):317–322.
   PubMed Web of Science ®Google Scholar
• Bagshaw SM, Laupland KB, Doig CJ, . Prognosis for long-term survival and renal recovery in critically ill patients with severe acute renal failure: a population-based study. Crit Care. 2005;9:R700–R709. [PMCID: PMC1414056] [PubMed: 16280066].
   PubMed Web of Science ®Google Scholar
• Jayakumar M, Prabahar MR, Fernando EM, Manorajan R, Venkatraman R, Balaraman V. Epidemiologic trend changes in acute renal failure—a tertiary center experience from South India. Ren Fail. 2006;28(5):405–410.
   PubMed Web of Science ®Google Scholar
• Kaballo BG, Khogali MS, Khalifa EH, Khaiii EA, Ei-Hassan AM, Abu-Aisha H. Patterns of “severe acute renal failure” in a referral center in Sudan: excluding intensive care and major surgery patients. Saudi J Kidney Dis Transpl. 2007;18(2):220–225.
   PubMedGoogle Scholar
• Ozturk S, Arpaci D, Yazici H, . Outcomes of acute renal failure patients requiring intermittent hemodialysis. Ren Fail. 2007;29(8):991–996.
   PubMed Web of Science ®Google Scholar
• Al-Azzam SI, Al-Husein BA, Abu-Dahoud EY, Dawoud TH, Al-Momany EM. Etiologies of acute renal failure in a sample of hospitalized Jordanian patients. Ren Fail. 2008; 30(4):373–376.
   PubMed Web of Science ®Google Scholar
• Kelly KJ, Dominguez JH. Rapid progression of diabetic nephropathy is linked to inflammation and episodes of acute renal failure. Am J Nephrol. 2010;32(5):469–475.
   PubMed Web of Science ®Google Scholar
• Ahmed AK, Kamath NS, El Kossi M, . The impact of stopping inhibitors of the renin-angiotensin system in patients with advanced chronic kidney disease. Nephrol Dial Transplant. 2010;25(12):3977–3982.
   PubMed Web of Science ®Google Scholar
• Longworth DL. Accountable care organizations, the patient-centered medical home, and health care reform: what does it all mean? Cleve Clin J Med. 2011;78(9):571–582.
   PubMed Web of Science ®Google Scholar
• The Concord Coalition. Escalating health care costs and the federal budget. 2009. Available at: http://www.concordcoalition.org/files/uploaded_for_nodes/docs/Iowa_Handout_final.pdf. Accessed September 12, 2011.
   Google Scholar
• The Henry J. Kaiser Family Foundation. Snapshots: Health care spending in the United States and selected OECD countries. 2011. Available at: http://www.kff.org/insurance/snapshot/OECD042111.cfm. Accessed September 12, 2011.
   Google Scholar
• Centers for Medicare and Medicaid Services. National health expenditure projections 2010–2020. 2010. Available at: https://www.cms.gov/NationalHealthExpendData/downloads/proj2010.pdf. Accessed December 20, 2011.
   Google Scholar
• Onuigbo M, Onuigbo NT. Reno-prevention: a new concept for re-engineering of nephrology practice: an economic impact and patient outcome analysis of two hypothetical patient scenarios in the CCU [Abstract]. J Am Soc Nephrol. 2011; 22:873A [PUB 124].
   Google Scholar
• Hammer M, Champy J. Reengineering the Corporation. A Manifesto for Business Revolution. Chapter 2—Reengineering: The Path to Change. New York, NY: HarperCollins; 2001.
   Google Scholar
• Yudkin JS, Richter B, Gale EA. Intensified glucose control in type 2 diabetes—whose agenda? Lancet. 2011;377(9773): 1220–1222.
   PubMed Web of Science ®Google Scholar